Aeromonas hydrophila Infections in Aquaculture: Pathogenesis and Antimicrobial Susceptibility
1. Introduction
Aeromonas hydrophila is a Gram-negative, facultative anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is a ubiquitous inhabitant of freshwater and brackish water environments and is recognized as one of the most significant opportunistic pathogens in global aquaculture [1, 2]. Infections caused by A. hydrophila result in Motile Aeromonad Septicemia (MAS), a disease complex characterized by hemorrhagic septicemia, ulcerative lesions, and high mortality rates, leading to substantial economic losses in the production of catfish, tilapia, carp, and other freshwater species [3, 4, 5].
The pathogen is equipped with a diverse arsenal of virulence factors that facilitate host colonization, tissue damage, and immune evasion. These include secreted exotoxins (aerolysin, hemolysins), proteases, lipases, and surface structures such as flagella and pili [6, 45, 69]. The regulation of many of these virulence determinants is under the control of quorum sensing (QS) systems, primarily the LuxI/LuxR-type AhyI/AhyR system, which mediates cell-density-dependent gene expression [80, 83, 86].
For decades, the primary strategy for controlling A. hydrophila outbreaks in aquaculture has been the prophylactic and therapeutic use of antibiotics. This reliance has driven the emergence and dissemination of multidrug-resistant (MDR) strains worldwide [64, 89, 176]. Resistance determinants are often carried on mobile genetic elements such as plasmids and integrons, facilitating their rapid spread within aquatic bacterial communities [89]. The resulting failure of antibiotic therapies has intensified the search for alternative control measures, including vaccines, probiotics, phage therapy, and anti-virulence compounds [2, 7, 8, 9].
This review provides a comprehensive examination of A. hydrophila pathogenesis in aquaculture, focusing on the molecular mechanisms of disease, modern diagnostic approaches, and the escalating challenge of antimicrobial resistance. The discussion is aligned with other relevant topics on this portal, including strategies for managing co-infections with viral pathogens such as Infectious Spleen and Kidney Necrosis Virus [10, 48] and parasitic agents like Ichthyophthirius multifiliis [65], as well as comparative resistance mechanisms seen in other aquatic bacteria like Streptococcus agalactiae [11, 3].
2. Pathogenesis and Virulence Mechanisms
The pathogenicity of A. hydrophila is multifactorial, relying on the coordinated expression of various virulence factors that allow it to adhere to, invade, and damage host tissues while subverting the host immune response.
2.1. Adhesion and Motility
The initial step in infection involves bacterial attachment to host mucosal surfaces, particularly the gills, skin, and gastrointestinal tract. This process is mediated by:
- Flagella: Polar flagella provide the primary means of motility in liquid environments, facilitating chemotaxis towards host tissues. Lateral flagella may contribute to adhesion and biofilm formation on solid surfaces [81].
- Pili and Fimbriae: Type IV pili, including the Tad (tight adherence) pilus system, are critical for adherence to epithelial cells and for twitching motility. Recombinant TadZ has been shown to induce protective immunity [102].
- Outer Membrane Proteins (OMPs): Porins and other OMPs, such as LamB, function in nutrient uptake and adhesion and are targets of the host immune system [101].
2.2. Exotoxins and Extracellular Products
The hallmark of A. hydrophila pathogenesis is the production of potent extracellular products (ECPs) that cause direct tissue damage.
- Aerolysin (AerA): This is the most critical pore-forming toxin. Aerolysin is secreted as an inactive protoxin, binds to host cell membranes (recognizing specific GPI-anchored proteins), and oligomerizes to form a heptameric beta-barrel channel. This disrupts ion gradients, leading to osmotic lysis of erythrocytes, epithelial cells, and immune cells [43, 45, 69, 84]. The inhibition of aerolysin activity is a primary target for novel anti-virulence therapies [6, 61, 66, 69].
- Hemolysins (HlyA, Ahh1): These are additional pore-forming cytotoxins that contribute to hemolytic activity and tissue necrosis [56, 64].
- Proteases and Lipases: Secreted metalloproteases and serine proteases degrade host connective tissue proteins, facilitating bacterial dissemination. Lipases and phospholipases disrupt host cell membranes and cause tissue liquefaction [38, 81, 86].
2.3. Quorum Sensing and Biofilm Formation
Bacterial cell-to-cell communication via QS is central to the regulation of virulence in A. hydrophila. The canonical system involves the AhyI synthase, which produces N-acyl homoserine lactone (AHL) signal molecules, and the AhyR receptor, which upon binding AHL, activates transcription of target genes including those for aerolysin, proteases, and biofilm matrix components [74, 80, 86].
Biofilm formation is a key survival strategy for A. hydrophila. Within a biofilm, bacteria are encased in a self-produced matrix of extracellular polymeric substances (EPS). This lifestyle provides protection against environmental stresses, disinfectants, and antibiotics. Biofilm-associated cells exhibit a distinct proteomic profile, with increased production of adhesins and degradative enzymes, which may enhance colonization and host invasion [7, 81]. The QS system is a primary target for anti-virulence strategies using compounds such as naringin, thymol, and methyl gallate [38, 82, 83].
2.4. Intracellular Survival and Immune Evasion
While primarily considered an extracellular pathogen, certain strains of A. hydrophila can survive and replicate within host phagocytes, such as macrophages. Intracellular survival is a key mechanism for immune evasion and dissemination. The two-component system EnvZ/OmpR plays a critical role in this process by regulating the expression of stress response genes (e.g., groEL, dnaK) involved in coping with reactive oxygen species (ROS) and maintaining metal ion homeostasis (Zn2+, Mg2+) within the phagosome [68].
flowchart TD
A[A. hydrophila Infection Cycle], > B{Host Entry}
B, > C[Adhesion & Colonization]
C, > D[Flagella, Pili, OMPs]
D, > E[Virulence Factor Production]
E, > F[Quorum Sensing Activation AhyI/AhyR]
F, > G[Exotoxin Secretion: Aerolysin, Hemolysins]
E, > H[Biofilm Formation]
G, > I[Host Tissue Damage]
H, > J[Antibiotic & Immune Evasion]
I, > K[Hemorrhagic Septicemia]
J, > K
K, > L[Host Immunological Response]
L, > M[Cytokine Storm, Inflammation]
M, > N[Mortality]
subgraph Anti-Virulence Strategies
O[QS Inhibitors: Naringin, Thymol]
P[Aerolysin Inhibitors: Luteolin, Apigenin]
end
O, > F
P, > G
3. Clinical Signs and Pathological Findings in Fish
The clinical presentation of MAS varies with host species, age, bacterial strain virulence, and environmental stressors, but typically manifests as an acute to peracute septicemia.
3.1. Gross Pathological Signs
Externally, affected fish exhibit:
- Hemorrhagic Septicemia: Diffuse or focal hemorrhages on the skin, fins, opercula, and vent. This is often the most striking gross lesion [4, 5, 12].
- Ulcerative Lesions: Shallow to deep cutaneous ulcers that may penetrate underlying muscle.
- Exophthalmia and Ascites: Protrusion of the eyeballs and abdominal distension due to fluid accumulation (dropsy) [4, 13, 14].
- Anemia: Pale gills and internal organs due to erythrocyte lysis [4].
Internally, common findings include:
- Petechial Hemorrhages: On the liver, kidney, spleen, and perivisceral fat.
- Organ Pallor and Necrosis: The liver and kidney may appear friable, swollen, and discolored [12, 15].
- Splenomegaly and Renomegaly: Enlargement of the spleen and kidney due to inflammation and congestion.
3.2. Histopathology
Microscopic examination reveals severe tissue destruction:
- Liver: Vacuolar degeneration of hepatocytes, focal necrosis, hemorrhage, and inflammatory cell infiltration [12].
- Kidney: Tubular necrosis, interstitial edema, glomerular degeneration, and hematopoietic tissue depletion [15].
- Gastrointestinal Tract: Enteritis characterized by necrosis of the mucosal epithelium, fusion of villi, and congestion of the lamina propria [16, 40, 54].
- Gills: Lamellar edema, epithelial hyperplasia, and necrosis.
4. Laboratory Diagnosis
Rapid and accurate diagnosis is essential for implementing effective control measures.
4.1. Conventional Culture and Biochemical Identification
Isolation from kidney, spleen, or liver tissue on selective media such as Rimler-Shotts (RS) medium or MacConkey agar is the first step. Phenotypic identification relies on Gram staining (Gram-negative rods), oxidase and catalase positivity, and resistance to the vibriostatic agent O/129. Commercial biochemical test strips (e.g., API 20E) can provide species-level identification, but may misidentify some Aeromonas species [64, 72].
4.2. Molecular Diagnostics
- Conventional and Real-Time PCR: PCR assays targeting species-specific genes such as the 16S rRNA gene, the aerolysin gene (aerA), or the hemolysin gene (hlyA) offer high sensitivity and specificity [64, 72, 77]. Real-time quantitative PCR (qPCR) allows for quantification of bacterial load and can differentiate between active infection and asymptomatic carriage [77].
- Recombinase Polymerase Amplification (RPA): For field-deployable diagnostics, RPA assays targeting the hemolysin gene provide a rapid (20 minutes), isothermal alternative to PCR. Real-time RPA has demonstrated high diagnostic sensitivity and specificity for A. hydrophila detection, making it suitable for point-of-care applications [88].
4.3. Proteomic Identification: MALDI-TOF MS
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has emerged as a powerful tool for rapid and reliable identification of A. hydrophila isolates. The technology generates a characteristic protein spectrum (mass fingerprint) that is compared against a reference database. MALDI-TOF MS can accurately distinguish A. hydrophila from closely related species such as A. veronii and A. caviae, providing results within minutes at a low consumable cost [64].
5. Antimicrobial Susceptibility and Resistance Mechanisms
The widespread use of antibiotics in aquaculture has selected for MDR A. hydrophila strains, severely compromising treatment options.
5.1. Resistance Phenotypes
A. hydrophila isolates frequently exhibit resistance to multiple classes of antibiotics, including:
- Beta-lactams: Resistance to penicillins, cephalosporins (1st and 2nd generation), and carbapenems is common. This is primarily mediated by chromosomally encoded and acquired beta-lactamases.
- Tetracyclines: Resistance genes (e.g., tet genes) are widespread.
- Sulfonamides and Trimethoprim: sul and dfr genes are frequently detected.
- Quinolones and Fluoroquinolones: Mutations in gyrase (gyrA) and topoisomerase (parC) genes, along with plasmid-mediated quinolone resistance (PMQR) determinants, confer resistance [64, 176].
5.2. Mechanisms of Resistance
Resistance is mediated by three fundamental strategies:
- Antibiotic Inactivation: Enzymatic degradation (e.g., beta-lactamases) or modification (e.g., aminoglycoside acetyltransferases) of the drug.
- Target Modification: Mutations in the drug target (e.g., DNA gyrase for quinolones, ribosomal binding sites for tetracyclines) that reduce binding affinity.
- Reduced Drug Accumulation: Efflux pumps (e.g., resistance-nodulation-division (RND) family pumps) that actively expel drugs, and decreased outer membrane permeability through porin loss [89].
5.3. Role of LysR-Type Transcriptional Regulators (LTTRs)
Recent genomic studies have highlighted the role of LTTRs as global regulators of antibiotic resistance in A. hydrophila. These proteins can modulate the expression of efflux pumps, porins, and other resistance genes, contributing to the mutlidrug resistance phenotype [89].
6. Alternative and Complementary Control Strategies
Given the widespread antimicrobial resistance, significant research efforts are focused on developing non-antibiotic-based control methods.
6.1. Vaccination
Vaccination is the cornerstone of prophylactic disease control. Various vaccine platforms have been developed:
- Inactivated (Bacterin) Vaccines: Formalin-killed whole cells are the most common type and can be administered via injection, immersion, or orally. Oral delivery is the most practical for mass vaccination [3, 17, 18, 19, 73].
- Live Attenuated Vaccines: These offer the potential for stronger and longer-lasting immunity but raise safety concerns regarding reversion to virulence.
- Subunit and Recombinant Vaccines: These use specific immunogenic proteins (e.g., aerolysin, OMPs, flagellin) to elicit a targeted immune response. Reverse vaccinology is being used to design multi-epitope vaccines based on aerolysin [43, 102].
- Nanovaccines: Encapsulating antigens in nanoparticles (e.g., chitosan) protects them from degradation in the gastrointestinal tract, improving oral delivery and efficacy [1, 20, 122].
6.2. Anti-Virulence Therapy
Disarming the pathogen without killing it reduces selective pressure for resistance. This approach targets quorum sensing (QS) and key virulence factors. Natural compounds such as genistein, naringin, thymol, luteolin, sanguinarine, and apigenin have been shown to inhibit aerolysin production and/or QS signaling, thereby attenuating pathogenicity and protecting fish in challenge models [6, 61, 66, 74, 82, 83, 84].
6.3. Probiotics and Prebiotics
Supplementation of feed with beneficial bacteria (e.g., Bacillus spp., Lactobacillus spp., Paenibacillus spp.) enhances the host's innate immune response, improves gut health, and competitively excludes pathogens [21, 42, 49, 52, 60, 78, 79]. Prebiotics such as dietary fibers can stimulate the growth of beneficial gut microbiota [22].
6.4. Bacteriophage Therapy
Lytic bacteriophages offer a highly specific and environmentally friendly alternative to antibiotics. Phages targeting A. hydrophila have been successfully isolated and characterized, demonstrating efficacy in reducing bacterial loads and mortality in experimental infections [9, 23, 47, 53, 55, 59, 67, 70, 76, 85, 138].
6.5. Plant-Derived Compounds (Phytobiotics)
A vast array of plant extracts and essential oils possess antimicrobial, anti-virulence, and immunostimulatory properties. Examples include turmeric oil, garlic-derived allicin, behenic acid, silymarin, and extracts from Withania somnifera, Cinnamomum verum, and Plectranthus amboinicus [24, 25, 26, 37, 58, 62, 65, 139].
7. Conclusion
Aeromonas hydrophila remains a formidable challenge to the sustainability of global aquaculture. Its complex pathogenic machinery, driven by a finely tuned QS system, allows it to cause devastating outbreaks of hemorrhagic septicemia. The widespread emergence of MDR strains has rendered traditional antibiotic therapy increasingly unreliable. Consequently, the future of disease management must transition from a reliance on antibiotics to a multi-faceted integrated approach. This strategy should combine robust biosecurity, vaccination using next-generation platforms (including nanovaccines), and the deployment of targeted alternative therapies such as phages, probiotics, and anti-virulence compounds. Continued investment in rapid molecular diagnostics (PCR, RPA) and high-throughput proteomic identification (MALDI-TOF MS) is essential for early detection and informed decision-making. A shift towards these sustainable, evidence-based practices is critical for mitigating the impact of A. hydrophila and securing the future of the aquaculture industry.
References
[1] Harshitha, M., Nayak, A., Disha, S., et al. Nanovaccines to Combat Aeromonas hydrophila Infections in Warm-Water Aquaculture: Opportunities and Challenges. Vaccines.
[2] Li, S., Dong, J., Zhou, S., et al. Antibiotic Alternative Strategies Against Aeromonas hydrophila Infections: New Trends and Advances. Reviews in Aquaculture.
[3] Monir, M.S., Yusoff, S., Zulperi, Z., et al. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus). BMC Veterinary Research.
[4] Wang, L., Prodhan, Z.H., SafiulAzam, F.M., et al. Study of Aeromonas Hydrophila Infections in Pelteobagrus Fulvidraco: In the Morphological and Hematological Symptoms. Journal.
[5] Wang, L., Prodhan, Z.H., Ao, L., et al. Morphological and Hematological Symptoms of Aeromonas Hydrophila Infections in Pelteobagrus Fulvidraco. American Journal of Surgery and Clinical Case Reports.
[6] Dong, J., Yan, T., Yang, Q., et al. Inhibitory Effect of Polydatin Against Aeromonas hydrophila Infections by Reducing Aerolysin Production. Frontiers in Veterinary Science.
[7] Rozi, R., Tyasningsih, W., Rahmahani, J., et al. Multiphase antibiofilm potential of shrimp-shell derived chitosan nanoparticles against Aeromonas hydrophila isolated from tropical aquaculture environments. Veterinary World.
[8] Miryala, K.R., Swain, B. Advances and Challenges in Aeromonas hydrophila Vaccine Development: Immunological Insights and Future Perspectives. Vaccines.
[9] Julaini, N., Wahjuningrum, D., Widanarni, et al. Isolation, Characterization, and In Vitro Evaluation of Bacteriophages for Controlling the Fish Pathogen Aeromonas hydrophila. Jurnal Ilmiah Perikanan dan Kelautan.
[10] Boregowda, K.K., Sankappa, N.M., Kallappa, G.S., et al. Co-infection of infectious spleen and kidney necrosis virus, Aeromonas hydrophila, and Aeromonas dhakensis in native endemic Canara pearlspot Etroplus canarensis of Western Ghats, India. Aquaculture International.
[11] Kurniawan, J., Waturangi, D., Julyantoro, P.G.S., et al. Ice nucleation active bacteria metabolites as antibiofilm agent to control Aeromonas hydrophila and Streptococcus agalactiae infections in Aquaculture. BMC Research Notes.
[12] Abd Hakim, M.M.B.H., Anshary, H., Djawad, M., et al. Pathogenicity of Aeromonas hydrophila on the liver function of African catfish (Clarias gariepinus). Biodiversitas Journal of Biological Diversity.
[13] Maryani, M., Monalisa, S.S., Rozik, M., et al. Curative Efficacy of Yellow Root (Arcangelisia flava) Extract Against Aeromonas hydrophila Bacterial Infection in Climbing Perch (Anabas testudineus). Jurnal Perikanan Universitas Gadjah Mada.
[14] Azizah, Z. Therapeutic Efficacy of Crinum Asiaticum Leaf Extract Against Aeromonas Hydrophila Infection in Juvenile Common Carp (Cyprinus Carpio L.). Aquatic Life Sciences.
[15] Zhou, Y., Zhu, R., Xie, L., et al. Histopathological and Molecular Insights into Grass Carp Kidney Responses to Co-Infection with Aeromonas hydrophila and Aeromonas veronii. Fishes.
[16] Li, P., Zeng, C., Liu, Y., et al. Grass carp HB-EGFa enhances resistance to Aeromonas hydrophila infection by fortifying gut mucosal barrier function. Fish and Shellfish Immunology.
[17] Yun, S., Lee, S.J., Giri, S., et al. Vaccination of fish against Aeromonas hydrophila infections using the novel approach of transcutaneous immunization with dissolving microneedle patches in aquaculture. Fish and Shellfish Immunology.
[18] Monir, M.S., Yusoff, M.S.M., Zamri-Saad, M., et al. Effect of an Oral Bivalent Vaccine on Immune Response and Immune Gene Profiling in Vaccinated Red Tilapia (Oreochromis spp.) during Infections with Streptococcus iniae and Aeromonas hydrophila. Biology.
[19] Mubeen, N., Abbas, F., Hafeez-ur-Rehman, M., et al. Immunopotential Induced in Culturable Carps Fed on Edible Bivalent Vaccine Against Aeromonas veronii and Aeromonas hydrophila. Aquaculture Research.
[20] Rajeswari, M., Thirumalaikumar, E., Emmanuel, E.F., et al. Oral delivery of chitosan-conjugated polyvalent vaccine on immune response and disease resistance against Aeromonas hydrophila, Aeromonas caviae, and Edwardsiella tarda in Koi carp Cyprinus carpio. Aquaculture International.
[21] Lin, P.H., Chen, S.W., Wen, Z., et al. Administration of the Potential Probiotic Paenibacillus ehimensis NPUST1 Enhances Expression of Indicator Genes Associated with Nutrient Metabolism, Growth and Innate Immunity against Aeromonas hydrophila and Streptococcus indie Infections in Zebrafish (Danio rerio). Fishes.
[22] Qosimah, D., Widyaputri, T., Ataullah, M., et al. Short-term fasting enhances the resistance of common carp (Cyprinus carpio) to Aeromonas hydrophila: Impacts on gut microbiota, glucose, and oxidative stress. Veterinary World.
[23] Han, P., Qin, H., Hao, C., et al. Isolation and genomic analysis of phage BUCT551 against drug-resistant Aeromonas hydrophila. Frontiers in Veterinary Science.
[24] Ravi, L., Kumar, A.K., Kumari, S., et al. Behenic Acid as a multi-target inhibiting antibacterial phytochemical against Vibrio parahaemolyticus and Aeromonas hydrophila for effective management of aquaculture infections: an in-silico, in-vitro & in-vivo experimentation. Journal of Biomolecular Structure and Dynamics.
[25] Dong, J., Tong, J., Li, S., et al. Turmeric Oil Interferes with Quorum Sensing as an Alternative Approach to Control Aeromonas hydrophila Infection in Aquaculture. Biology.
[26] Silva, J., Vilar, F., Lima, G., et al. Plectranthus amboinicus Essential Oil Incorporated into Fish Feed Shows Strong Antimicrobial Activity against Aeromonas hydrophila, an Opportunistic Bacterium of Aquaculture. Journal of the Brazilian Chemical Society.
[27] Guha, R., Lakshmi, S., Krebs, T., et al. Efficacy of a novel oral bivalent vaccine with fucoidan as adjuvant against Aeromonas hydrophila and Edwardsiella tarda infections in Nile tilapia aquaculture. Fish and Shellfish Immunology.
[28] Mondal, H., Thomas, J. Treatment of Aeromonas hydrophila and Vibrio parahaemolyticus infections in Macrobrachium rosenbergii using bioactive compounds from marine Actinomycetes - an alternative to synthetic antibiotics. Microbial Pathogenesis.
[29] Monir, M.S., Yusoff, S., Zulperi, Z., et al. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis spp.). Journal.
[30] Nair, R.R., John, K.R., Das, B., et al. Modulation of immune and pathological responses in Nile tilapia by single and co-infections with Lactococcus garvieae and Aeromonas hydrophila. Aquaculture International.
[31] James, T., Rahiman, K.M., Sebastian, D., et al. The combinational effect of avian IgY antibodies and broad-spectrum antibiotics (ciprofloxacin and chloramphenicol) in vitro reduces the incidence of Aeromonas hydrophila. Journal of Applied Aquaculture.
[32] Sun, S., Chen, J., Cui, P., et al. Evaluation of Immunoprotective Activities of White Button Mushroom (Agaricus bisporus) Water Extract Against Major Pathogenic Bacteria (Aeromonas hydrophila or Vibrio fluvialis) in Goldfish (Carassius auratus). Animals.
[33] He, Y., Tang, D., Lin, J., et al. A Small-Molecular-Weight Bacteriocin-like Inhibitory Substance (BLIS) UI-11 Produced by Lactobacillus plantarum HYH-11 as an Antimicrobial Agent for Aeromonas hydrophila. Veterinary Sciences.
[34] Miyashita, A., Mikami, K., Nakajima, H., et al. Silkworm (Bombyx mori) as a novel infection model for fish-derived Aeromonas hydrophila. Drug Discoveries & Therapeutics.
[35] Cui, P., Chen, J., Xiao, H., et al. Assessment of Egg Yolk IgY Antibodies Against Live or Inactivated Aeromonas hydrophila for Polyvalent Passive Immunization in Goldfish (Carassius auratus). Fishes.
[36] Maolana, I., Rudi, M., Tarigan, D.J. The Effect of Kepok Banana (Musa balbisiana) Peel Extract on the Survival of Sangkuriang Catfish (Clarias gariepinus) Infected with Aeromonas hydrophila. *Si